Capital Guardian Trust’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Capital Guardian Trust's LLY Position: Q2 2019 in Review
Capital Guardian Trust reduced its Eli Lilly (LLY) stake by 24% in Q2 2019, selling an estimated $16.1M and leaving 438,439 shares worth $48.6M. The position accounts for 0.65% of the portfolio, ranked #62.
Capital Guardian Trust first reported a position in LLY in Q2 2013 and has held it in 25 quarters since. The position peaked at $147M in Q4 2015. 1,516 funds tracked by Wall St. Rank hold LLY as of Q2 2019.
- Capital Guardian Trust held 438,439 shares of Eli Lilly worth $48.6M as of Q2 2019.
- Capital Guardian Trust sold 136,431 Eli Lilly shares in Q2 2019, an estimated $16.1M.
- Eli Lilly made up 0.65% of Capital Guardian Trust's portfolio in Q2 2019, its #62 holding.
- Capital Guardian Trust first reported a position in Eli Lilly in Q2 2013 and has held it in 25 quarters since.
- Capital Guardian Trust's Eli Lilly position peaked at $147M in Q4 2015.
- 1,516 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2019.
Based on Capital Guardian Trust's 13F filing for Q2 2019, filed 14 Aug 2019.